BPG is committed to discovery and dissemination of knowledge
Case Report
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Feb 6, 2022; 10(4): 1381-1387
Published online Feb 6, 2022. doi: 10.12998/wjcc.v10.i4.1381
Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report
Wen-Yu Liu, Jia-Rong Zhang, Xian-Ming Xu, Tian-Yi Ye
Wen-Yu Liu, Xian-Ming Xu, Tian-Yi Ye, Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201600, China
Jia-Rong Zhang, Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Author contributions: Liu WY and Ye TY collected the patient data, contributed to conception of the manuscript, reviewed the literature, and wrote the paper; the surgery was performed by Xu XM and Zhang JR; Xu XM and Zhang JR were responsible for the revision of the manuscript for important intellectual content; all authors read and approved the final manuscript.
Informed consent statement: All study participants or their legal guardian provided informed written consent about personal and medical data collection prior to study enrolment.
Conflict-of-interest statement: The authors declare that they have no competing interests.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Tian-Yi Ye, MD, Doctor, Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No. 650 Xinsongjiang Road, Songjiang District, Shanghai 201600, China. yty1119@sina.com
Received: September 3, 2021
Peer-review started: September 3, 2021
First decision: November 11, 2021
Revised: November 21, 2021
Accepted: December 25, 2021
Article in press: December 25, 2021
Published online: February 6, 2022
Processing time: 142 Days and 17.9 Hours
Core Tip

Core Tip: Toxic epidermal necrolysis (TEN) is a rare life-threatening cutaneous drug reaction, which may be a threat to the mother and the fetus during pregnancy. In our case, the patient’s condition began to improve when the ritodrine was stopped. So ritodrine hydrochloride could be a cause of TEN. If a rash occurs during the use of ritodrine, it is urgent for doctors to consider the side-effect of the drug and to stop its use immediately. The use of tocolytic agents should be individualized and depend on potential adverse events and maternal condition.

Write to the Help Desk